Travaux scientifiques

Prof. Dr. İlim Irmak

66 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. Lung function outcomes of cystic fibrosis patients after early‐life pulmonary exacerbations: National registry analysis

    Pediatrics International, 2026

    DOI 10.1111/ped.70345 PMID 41660807 Source : OpenAlex

  2. Clinical features associated with Pseudomonas aeruginosa colonization in children under 2 years of age: a retrospective study of Cystic Fibrosis Registry

    The Turkish Journal of Pediatrics, 2026

    DOI 10.24953/turkjpediatr.2026.7593 PMID 42497434 Texte intégral en libre accèsSource : OpenAlex

  3. Factors associated with pulmonary function decline of patients in the cystic fibrosis registry of Turkey: A retrospective cohort study

    Pediatric Pulmonology, 2024

    DOI 10.1002/ppul.27165 PMID 38980199 2 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  4. Can computed tomography findings and radiomics analysis of mediastinal lymph nodes differentiate between sarcoidosis and lymphoma?

    Clinical Radiology, 2024

    DOI 10.1016/j.crad.2024.08.022 PMID 39261216 5 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  5. Patients with cystic fibrosis who could not receive the CFTR modulator treatment: What did they lose in 1 year?

    Pediatric Pulmonology, 2023

    DOI 10.1002/ppul.26535 PMID 37278544 10 citations (Europe PMC) Source : OpenAlex

  6. Clinical characteristics of patients requiring lung transplantation referral in national cystic fibrosis registry data

    The Turkish Journal of Pediatrics, 2023

    DOI 10.24953/turkjped.2021.4930 PMID 37114691 2 citations (Europe PMC) Source : OpenAlex

  7. Evaluation of respiratory function at 6 years of age in patients with cystic fibrosis with frequent pulmonary exacerbations in the first 2 years of life

    European Respiratory Journal, 2023

    DOI 10.1183/13993003.congress-2023.pa5012 Source : OpenAlex

  8. A case‐control study of the effects of Aspergillus clinical phenotypes on pulmonary functions in patients with cystic fibrosis

    Pediatric Pulmonology, 2023

    DOI 10.1002/ppul.26319 PMID 36651101 Source : OpenAlex

  9. Bone Mineral Density in Lung Transplant Recipients: Experience of A Referral Lung Transplantation Center

    Turkish Journal of Internal Medicine, 2023

    DOI 10.46310/tjim.1206443 Source : OpenAlex

  10. The success of the Cystic Fibrosis Registry of Turkey for improvement of patient care

    Pediatric Pulmonology, 2022

    DOI 10.1002/ppul.25852 PMID 35102722 7 citations (Europe PMC) Source : OpenAlex

  11. “Early” Pseudomonas aeruginosa colonization in cystic fibrosis patients

    European Respiratory Journal, 2022

    DOI 10.1183/13993003.congress-2022.457 Source : OpenAlex

  12. The association of antiviral drugs with COVID-19 morbidity: The retrospective analysis of a nationwide COVID-19 cohort

    Frontiers in Medicine, 2022

    DOI 10.3389/fmed.2022.894126 PMID 36117966 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  13. Post−discharge mortality in the first wave of COVID−19 in Turkey

    Asian Pacific Journal of Tropical Medicine, 2022

    DOI 10.4103/1995-7645.361853 Source : OpenAlex

  14. Association Between Known Close Contact History and Severity of COVID-19 Pneumonia: A Preliminary Evidence Supporting Importance of Filiation

    Turkish Thoracic Journal, 2022

    DOI 10.5152/turkthoracj.2022.21091 PMID 35579225 Texte intégral en libre accèsSource : OpenAlex

  15. The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients

    Respiratory Medicine, 2021

    DOI 10.1016/j.rmed.2021.106433 PMID 33957434 32 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  16. Factors related to oxygen desaturation during flexible bronchoscopy and endobronchial ultrasound

    Tuberkuloz ve Toraks, 2021

    DOI 10.5578/tt.20219803 PMID 34256504 7 citations (Europe PMC) Source : OpenAlex

  17. AI-Based Quantitative CT Analysis of Temporal Changes According to Disease Severity in COVID-19 Pneumonia

    Journal of Computer Assisted Tomography, 2021

    DOI 10.1097/rct.0000000000001224 PMID 34581706 7 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  18. Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls

    Rheumatology International, 2021

    DOI 10.1007/s00296-021-04965-6 PMID 34515808 5 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  19. Cuban Blue Scorpion Venom and Lung Carcinoma: Is it Always True What Does Not Kill Me Makes Me Stronger?

    Turkish Thoracic Journal, 2021

    DOI 10.5152/turkthoracj.2021.20202 PMID 35110239 Texte intégral en libre accèsSource : OpenAlex

  20. Clinical implications of fungal isolation from sputum in adult patients with cystic fibrosis

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021

    DOI 10.3906/sag-2006-94 PMID 33433970 Texte intégral en libre accèsSource : OpenAlex

  21. The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients

    European Respiratory Journal, 2021

    DOI 10.1183/13993003.congress-2021.pa3817 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  22. Risk factors of unfavorable outcomes in chronic obstructive pulmonary disease patients treated with noninvasive ventilation for acute hypercapnic respiratory failure

    The Clinical Respiratory Journal, 2020

    DOI 10.1111/crj.13245 PMID 32762016 5 citations (Europe PMC) Source : OpenAlex

  23. Lung and kidney perfusion deficits diagnosed by dual-energy computed tomography in patients with COVID-19-related systemic microangiopathy

    European Radiology, 2020

    DOI 10.1007/s00330-020-07155-3 PMID 32860146 55 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  24. Visual and software-based quantitative chest CT assessment of COVID-19: correlation with clinical findings

    Diagnostic and Interventional Radiology, 2020

    DOI 10.5152/dir.2020.20407 PMID 32876569 22 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  25. Unclear Issues Regarding COVID-19

    Eurasian Journal of Medicine, 2020

    DOI 10.5152/eurasianjmed.2020.20092 PMID 32612430 8 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  26. The comparison of the survival rates of intensive and palliative care units

    Tuberkuloz ve Toraks, 2020

    DOI 10.5578/tt.69753 PMID 33295722 3 citations (Europe PMC) Source : OpenAlex

  27. RETROSPECTIVE ANALYSIS OF COST AND FACTORS AFFECTING MORTALITY IN ELDERLY PATIENTS IN THE INTENSIVE CARE UNIT

    The Turkish Journal of Geriatrics, 2020

    DOI 10.31086/tjgeri.2020.137 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  28. Clinical Characteristics and Outcome of ANCA-Associated Vasculitis; Experience of A Single Reference Vasculitis Center

    Acta Medica, 2020

    DOI 10.32552/2020.actamedica.509 Texte intégral en libre accèsSource : OpenAlex

  29. 21st Turkish Thoracic Society Annual Congress Abstract Book

    Turkish Thoracic Journal, 2020

    DOI 10.5152/turkthoracj2018.100418 PMID 31651395 Texte intégral en libre accèsSource : OpenAlex

  30. Life advices in patients with tracheostomy: Rational antibiotic use and cerebro-vascular prophylaxis-physiotherapy

    Medicine Science | International Medical Journal, 2019

    DOI 10.5455/medscience.2019.08.9126 Texte intégral en libre accèsSource : OpenAlex

  31. Comparison of the Effects of Smoking and Smokeless Tobacco “Maras Powder” Use on Pulmonary Function, Electrocardiogram and Other Parameters

    European Archives of Medical Research, 2019

    DOI 10.4274/eamr.galenos.2019.94809 Source : OpenAlex

  32. Mortality Evaluation in Patients with Provoked and Malignancy Related Pulmonary Thromboembolism: A Retrospective Cohort Study

    Turkish Thoracic Journal, 2019

    DOI 10.5152/turkthoracj.2019.360 Texte intégral en libre accèsSource : OpenAlex

  33. Provoke ve Malignite İlişkili Pulmoner Emboli Hastalarında Mortalite Değerlendirilmesi Retrospektif Kohort Çalışma

    AYBU AVESIS, 2019

    Source : OpenAlex

  34. Erişkin Yaşta Tanı Alan Sağ Pulmoner Aplazi

    AYBU AVESIS, 2019

    Source : OpenAlex

  35. Current Statement of Intensive Care Units in Turkey: Data obtained from 67 Centers

    Turkish Thoracic Journal, 2018

    DOI 10.5152/turkthoracj.2018.170104 PMID 30322437 4 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  36. Tracheostomy practices in intensive care units in Turkey: Turkish Thoracic Society critical care assembly point prevelance trial

    AYBU AVESIS, 2018

    Source : OpenAlex

  37. TÜRKIYE’DE YOĞUN BAKIM ÜNITELERINDEKITRAKEOSTOMI UYGULAMALARI: TÜRK TORAKSDERNEĞI SOLUNUM YETMEZLIĞI VE YOĞUN BAKIMÇALIŞMA GRUBU NOKTA PREVALANS ÇALIŞMASI

    Erciyes University - AVESIS, 2018

    Source : OpenAlex

  38. TÜRKIYE’DE YOĞUN BAKIM ÜNITELERINDEKITRAKEOSTOMI UYGULAMALARI: TÜRK TORAKSDERNEĞI SOLUNUM YETMEZLIĞI VE YOĞUN BAKIMÇALIŞMA GRUBU NOKTA PREVALANS ÇALIŞMASI

    AYBU AVESIS, 2018

    Source : OpenAlex

  39. Türkiye’deki Yoğun Bakım Ünitelerindeki Trakeostomi Uygulamaları: Türk Toraks Derneği Solunum Yetmezliği ve Yoğun Bakım Çalışma Grubu Nokta Prevalans Çalışması

    AYBU AVESIS, 2018

    Source : OpenAlex

  40. TÜRKIYE’DE YOĞUN BAKIM ÜNITELERINDEKI TRAKEOSTOMI UYGULAMALARI: TÜRK TORAKS DERNEĞI SOLUNUM YETMEZLIĞI VE YOĞUN BAKIM ÇALIŞMA GRUBU NOKTA PREVALANS ÇALIŞMASI

    Bursa Uludag University - AVESIS, 2018

    Source : OpenAlex

  41. Severity of acidosis affects long-term survival in COPD patients with hypoxemia after intensive care unit discharge

    International Journal of COPD, 2018

    DOI 10.2147/copd.s159504 PMID 29780244 9 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  42. Inflammatory Markers in Patients Using Domiciliary Non-invasive Mechanical Ventilation: C Reactive Protein, Procalcitonin, Neutrophil Lymphocyte Ratio

    Frontiers in Public Health, 2018

    DOI 10.3389/fpubh.2018.00245 PMID 30234089 6 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  43. Neutrophil-to-Lymphocyte Ratio: Is it Higher in Bronchiectasis than in COPD?

    DOAJ (DOAJ: Directory of Open Access Journals), 2018

    DOI 10.14744/scie.2018.54254 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  44. Respiratory Mechanics: New Concepts

    Güncel Göğüs Hastalıkları Serisi, 2018

    DOI 10.5152/gghs.2018.001 Source : OpenAlex

  45. Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker

    International Journal of COPD, 2017

    DOI 10.2147/copd.s147261 PMID 29200843 19 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  46. Patient profile at intensive care units in Turkey: 922 patients multicenter prevalence study

    European Respiratory Journal, 2017

    DOI 10.1183/1393003.congress-2017.pa2129 Source : OpenAlex

  47. Acceptance criteria for intensive care: we need new definitions and legislations for futile treatment!

    European Respiratory Journal, 2017

    DOI 10.1183/1393003.congress-2017.pa2109 Source : OpenAlex

  48. Patient profile at intensive care units in Turkey: 922 patients multicenter prevalence study.

    AYBU AVESIS, 2017

    Source : OpenAlex

  49. Türkiyede Yoğun Bakım Ünitelerinde takipedilen hasta profili:922 hastalınçok merkezli nokta prevalans çalışması

    AYBU AVESIS, 2017

    Source : OpenAlex

  50. Türkiye’de yoğun bakım ünitelerinde takip edilen hasta profili: 922 hastalı çok merkezli nokta prevalans çalışması

    AYBU AVESIS, 2017

    Source : OpenAlex